As per the business intelligence report titled ‘Aquaculture Healthcare Market Size By Product, By Species , By Infections, By Route of Administration, By Distribution Channel, Regional Outlook, Price Trends, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’ available with Market Study Report, global aquaculture healthcare market is estimated to acquire significant traction in terms of demand during 2020-2026.
 

For the record, aquaculture refers to the farming of aquatic organisms such as crustaceans, fish, aquatic plants, and molluscs. Aquaculture healthcare is the maintenance of the health of these organisms to make sure they are safe for consumption.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2525385/
 

Based on product type, global aquaculture healthcare market is bifurcated into vaccines, medicated feed additives, and drugs. Among these, the vaccine product segment is projected to register a 6.4% CAGR through 2026, owing to rising occurrence of antibiotic resistance and increasing adoption of vaccines for infection prevention in fish due to their high efficacy.
 

With regards to species, the crustacean species segment is anticipated to grow with a CAGR of 6.5% over the forecast period. Rising consumption of prawns as well as shrimps is fostering the expansion of the segment.
 

Moving on to infection type, global aquaculture healthcare industry is divided into parasitic infection, fungal infection, bacterial infection, and viral infection. The fungal infection segment reflected a revenue of USD 19.9 million in the year 2019 and is expected to grow considerably through 2026. High susceptibility of fishes towards fungal infections is propelling the expansion of the segment. 
 

Elaborating on the route of administration, the injectable segment accounted for around 55% of the global aquaculture healthcare market share in 2019 and is predicted to record similar growth during the analysis timeframe. Efficient direct stimulation of immune response facilitated trough injections is favoring the expansion of the segment.
 

Speaking of distribution channel, the online stores segment is set to acquire noteworthy profits over 2020-2026, owing to high availability of wide variety of aquaculture drugs on online platforms along with increasing consumer preference towards e-shopping.
 

From a geographical point of view, Latin America aquaculture healthcare market reached a valuation of USD 110 million in the year 2019 and is estimated to exhibit a robust CAGR of 6% over 2020-2026. Escalating demand for aquaculture healthcare due to the proximity of the Caribbean Sea is bolstering the expansion of the regional market.
 

Prominent companies that define the global aquaculture healthcare industry trends are Zoetis Inc., Zeal Aqua Ltd., Virbac, Vetoquinol S.A., Merck & Co., Inc., d.b.a. Merck Sharp & Dohme, Elanco Animal Health Incorporated, DuPont de Nemours, Inc., Ceva Santé Animale, Benchmark Holdings plc, and Archer-Daniels-Midland Company (ADM).